Baolingbao Biology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: FMCG
  • ISIN: CNE100000FL1
CNY
8.91
-0.2 (-2.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
708.95
680.12
564.23
643.03
629.82
547.03
554.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
708.95
680.12
564.23
643.03
629.82
547.03
554.46
Raw Material Cost
626.31
594.02
502.10
574.39
552.50
499.48
544.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.73
2.89
3.12
3.38
3.20
3.34
3.73
Selling and Distribution Expenses
29.37
26.87
23.77
27.22
25.73
20.59
0.00
Other Expenses
0.25
-0.14
-0.09
-0.16
-0.12
-0.24
-0.00
Total Expenditure (Excl Depreciation)
660.91
622.39
528.06
603.41
580.22
520.99
548.45
Operating Profit (PBDIT) excl Other Income
48
57.699999999999996
36.2
39.6
49.6
26
6
Other Income
4.54
3.55
-16.33
1.73
8.61
3.75
3.95
Operating Profit (PBDIT)
86.04
95.05
47.19
74.44
89.36
62.01
40.69
Interest
2.73
2.89
3.12
3.38
3.20
3.34
3.73
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
82.64
86.10
62.13
68.64
77.32
47.55
9.70
Depreciation
34.16
34.16
32.74
32.74
32.64
32.64
31.52
Profit Before Tax
49.15
58.01
11.33
38.32
53.52
26.04
9.72
Tax
7.44
9.17
0.84
6.17
8.49
4.46
0.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.32
50.36
10.09
31.74
46.16
23.17
7.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.32
50.36
10.09
31.74
46.16
23.17
7.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.32
50.36
10.09
31.74
46.16
23.17
7.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,123.02
2,087.83
2,041.53
2,034.72
1,998.52
1,955.76
1,983.49
Earnings per share (EPS)
0.11
0.14
0.03
0.09
0.12
0.06
0.02
Diluted Earnings per share
0.11
0.14
0.03
0.09
0.12
0.06
0.02
Operating Profit Margin (Excl OI)
6.68%
8.43%
5.45%
6.22%
7.64%
4.68%
0.19%
Gross Profit Margin
11.75%
13.55%
7.81%
11.05%
13.68%
10.73%
7.44%
PAT Margin
5.97%
7.4%
1.79%
4.94%
7.33%
4.24%
1.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.25% vs 20.54% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -16.07% vs 399.01% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -10.93% vs 44.09% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -6.90% vs -6.45% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Baolingbao Biology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
708.95
0
708.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
708.95
0
708.95
Raw Material Cost
626.31
0
626.31
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.73
0
2.73
Selling and Distribution Expenses
29.37
0
29.37
Other Expenses
0.25
0.00
0.25
Total Expenditure (Excl Depreciation)
660.91
0
660.91
Operating Profit (PBDIT) excl Other Income
48.04
0.00
48.04
Other Income
4.54
0
4.54
Operating Profit (PBDIT)
86.04
0
86.04
Interest
2.73
0
2.73
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
82.64
0
82.64
Depreciation
34.16
0
34.16
Profit Before Tax
49.15
0
49.15
Tax
7.44
0
7.44
Provisions and contingencies
0
0
0.00
Profit After Tax
42.32
0
42.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.32
0
42.32
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.32
0
42.32
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,123.02
0
2,123.02
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
6.68%
0%
0.00
6.68%
Gross Profit Margin
11.75%
0%
0.00
11.75%
PAT Margin
5.97%
0%
0.00
5.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 70.90 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.25% vs 20.54% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.58% vs -5.55% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -16.07% vs 399.01% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.44% vs 194.27% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -10.93% vs 44.09% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.87% vs 91.02% in Jun 2024

Quarterly - Interest
Interest 0.27 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -6.90% vs -6.45% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -15.62% vs -61.90% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.68%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024